Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.35%32.86M | 0.29%30.64M | -2.91%29.82M | 7.68%122.97M | 31.1M | 30.61M | 30.55M | 30.71M | 21.00%114.2M | 15.14%94.38M |
| Cost of revenue | 2.79%24.72M | -0.84%22.83M | -0.03%23.65M | 4.84%95.53M | 23.8M | 24.05M | 23.02M | 23.66M | 15.41%91.12M | 12.25%78.96M |
| Gross profit | 24.10%8.14M | 3.77%7.81M | -12.57%6.16M | 18.89%27.44M | 7.3M | 6.56M | 7.53M | 7.05M | 49.65%23.08M | 32.63%15.42M |
| Operating expense | 105.75%5.73M | -18.88%3.8M | -8.52%3.47M | 13.63%13.73M | 3.46M | 2.78M | 4.68M | 3.79M | 28.61%12.08M | 10.43%9.39M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 9.46%4.42M | 0.50%4.04M |
| Selling and administrative expenses | 105.75%5.73M | -18.88%3.8M | -8.52%3.47M | 13.47%13.73M | --3.46M | --2.78M | --4.68M | --3.79M | 217.94%12.1M | 19.24%3.81M |
| -General and administrative expense | 105.75%5.73M | -18.88%3.8M | -8.52%3.47M | 13.47%13.73M | --3.46M | --2.78M | --4.68M | --3.79M | 217.94%12.1M | 19.24%3.81M |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 12.24%1.64M | 20.93%1.46M |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 12.24%1.64M | 20.93%1.46M |
| Rent and land expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -7.78%83K | -13.46%90K |
| Other operating expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---17.21K | ---- |
| Total other operating income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Operating profit | -36.16%2.41M | 40.96%4.02M | -17.28%2.7M | 24.67%13.71M | 3.85M | 3.77M | 2.85M | 3.26M | 82.45%11M | 93.14%6.03M |
| Net non-operating interest income (expenses) | -105.56%-259K | -73.17%-213K | -31.58%-175K | 79.58%-117.11K | -203K | -126K | -123K | -133K | 9.97%-573.49K | -75.97%-637K |
| Non-operating interest income | ---- | ---- | ---- | 14,588.54%467.98K | ---- | ---- | ---- | ---- | --3.19K | ---- |
| Non-operating interest expense | 105.56%259K | 73.17%213K | 31.58%175K | 1.46%585.09K | --203K | --126K | --123K | --133K | -9.47%576.68K | -20.18%637K |
| Net investment income | -79.13%267.73K | 16.61%1.28M | 40.66%1.1M | |||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -46.04%1.13K | 0 | 0 | 100.30%2.09K | -1,442.22%-694K | |||||
| Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5,400.00%55K | --1K |
| Less:Other special charges | ---- | ---- | ---- | -662.07%-1.11K | ---- | ---- | ---- | ---- | 99.85%-145 | -59.32%-94K |
| Less:Write off | ---- | ---- | ---- | 98.97%-20 | --0 | ---- | --0 | ---- | -100.25%-1.94K | 656.73%787K |
| Other non-operating income (expenses) | 414.29%198K | 431.88%367K | 245.91%761K | 26.88%93.64K | 589K | -63K | 69K | 220K | -78.36%73.8K | -24.89%341K |
| Income before tax | -34.50%2.35M | 49.19%4.17M | -1.91%3.28M | 18.44%13.96M | 4.23M | 3.58M | 2.8M | 3.35M | 91.97%11.78M | 55.39%6.14M |
| Income tax | 4.28%756K | -16.68%954K | 18.12%815K | 17.76%3.63M | 1.07M | 725K | 1.15M | 690K | 121.68%3.08M | 66.47%1.39M |
| Net income | -44.33%1.59M | 94.91%3.22M | -7.12%2.47M | 18.68%10.33M | 3.16M | 2.86M | 1.65M | 2.66M | 83.27%8.7M | 52.42%4.75M |
| Net income continuous operations | -44.33%1.59M | 94.91%3.22M | -7.12%2.47M | 18.68%10.33M | --3.16M | --2.86M | --1.65M | --2.66M | 83.27%8.7M | 52.42%4.75M |
| Noncontrolling interests | -32K | 0 | ||||||||
| Net income attributable to the company | -44.33%1.59M | 94.91%3.22M | -5.91%2.5M | 18.68%10.33M | 3.16M | 2.86M | 1.65M | 2.66M | 83.27%8.7M | 52.42%4.75M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -44.33%1.59M | 94.91%3.22M | -5.91%2.5M | 18.68%10.33M | 3.16M | 2.86M | 1.65M | 2.66M | 83.27%8.7M | 52.42%4.75M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -61.46%0.0037 | 88.16%0.0069 | -5.12%0.0056 | 18.68%0.023 | 0.0096 | 0.0096 | 0.0037 | 0.0059 | 83.27%0.0193 | 52.43%0.0106 |
| Diluted earnings per share | -61.46%0.0037 | 88.16%0.0069 | -5.12%0.0056 | 18.68%0.023 | 0.0096 | 0.0096 | 0.0037 | 0.0059 | 83.27%0.0193 | 52.43%0.0106 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.